154 related articles for article (PubMed ID: 19202553)
1. Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastoma.
Van Maerken T; Sarkar D; Speleman F; Dent P; Weiss WA; Fisher PB
J Cell Physiol; 2009 Jun; 219(3):707-15. PubMed ID: 19202553
[TBL] [Abstract][Full Text] [Related]
2. Progression elevated gene-3 promoter (PEG-Prom) confers cancer cell selectivity to human polynucleotide phosphorylase (hPNPase(old-35))-mediated growth suppression.
Chan I; Lebedeva IV; Su ZZ; Sarkar D; Valerie K; Fisher PB
J Cell Physiol; 2008 May; 215(2):401-9. PubMed ID: 17960560
[TBL] [Abstract][Full Text] [Related]
3. Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene.
Leszczyniecka M; Su ZZ; Kang DC; Sarkar D; Fisher PB
Gene; 2003 Oct; 316():143-56. PubMed ID: 14563561
[TBL] [Abstract][Full Text] [Related]
4. Defining the mechanism by which IFN-beta dowregulates c-myc expression in human melanoma cells: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35).
Sarkar D; Park ES; Fisher PB
Cell Death Differ; 2006 Sep; 13(9):1541-53. PubMed ID: 16410805
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
6. Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammation.
Sarkar D; Lebedeva IV; Emdad L; Kang DC; Baldwin AS; Fisher PB
Cancer Res; 2004 Oct; 64(20):7473-8. PubMed ID: 15492272
[TBL] [Abstract][Full Text] [Related]
7. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
[TBL] [Abstract][Full Text] [Related]
8. Activation of double-stranded RNA dependent protein kinase, a new pathway by which human polynucleotide phosphorylase (hPNPase(old-35)) induces apoptosis.
Sarkar D; Park ES; Barber GN; Fisher PB
Cancer Res; 2007 Sep; 67(17):7948-53. PubMed ID: 17804700
[TBL] [Abstract][Full Text] [Related]
9. Identification of genes potentially regulated by human polynucleotide phosphorylase (hPNPase old-35) using melanoma as a model.
Sokhi UK; Bacolod MD; Dasgupta S; Emdad L; Das SK; Dumur CI; Miles MF; Sarkar D; Fisher PB
PLoS One; 2013; 8(10):e76284. PubMed ID: 24143183
[TBL] [Abstract][Full Text] [Related]
10. Analysis of global changes in gene expression induced by human polynucleotide phosphorylase (hPNPase(old-35)).
Sokhi UK; Bacolod MD; Emdad L; Das SK; Dumur CI; Miles MF; Sarkar D; Fisher PB
J Cell Physiol; 2014 Dec; 229(12):1952-62. PubMed ID: 24729470
[TBL] [Abstract][Full Text] [Related]
11. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
[TBL] [Abstract][Full Text] [Related]
12. Transductional and transcriptional targeting of adenovirus for clinical applications.
Glasgow JN; Bauerschmitz GJ; Curiel DT; Hemminki A
Curr Gene Ther; 2004 Mar; 4(1):1-14. PubMed ID: 15032610
[TBL] [Abstract][Full Text] [Related]
13. Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells.
Das SK; Sokhi UK; Bhutia SK; Azab B; Su ZZ; Sarkar D; Fisher PB
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11948-53. PubMed ID: 20547861
[TBL] [Abstract][Full Text] [Related]
14. Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor.
Lee EM; Hong SH; Lee YJ; Kang YH; Choi KC; Choi SH; Kim IH; Lim SJ
J Cancer Res Clin Oncol; 2004 Mar; 130(3):169-77. PubMed ID: 14677059
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-based purging of multiple myeloma cells.
Teoh G; Chen L; Urashima M; Tai YT; Celi LA; Chen D; Chauhan D; Ogata A; Finberg RW; Webb IJ; Kufe DW; Anderson KC
Blood; 1998 Dec; 92(12):4591-601. PubMed ID: 9845525
[TBL] [Abstract][Full Text] [Related]
16. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
[TBL] [Abstract][Full Text] [Related]
17. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells.
Li Y; Zhuo B; Yin Y; Han T; Li S; Li Z; Wang J
Biochem Biophys Res Commun; 2017 Sep; 491(1):134-139. PubMed ID: 28711493
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration.
Yao X; Yoshioka Y; Morishige T; Eto Y; Narimatsu S; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
Biol Pharm Bull; 2010; 33(6):1073-6. PubMed ID: 20522982
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
